The market for biochemists is changing: pharma and biotech beckon, the path to academic tenure is strewn with obstacles:
"A decade after 26 members of the entering class of 1991 earned their Ph.D.s from Yale's elite molecular biophysics and biochemistry program, only one holds a tenured faculty position. But is an exodus from academia a bad thing?"
from And Then There Was One, Science 19 September 2008: 1622-1628.
Sunday, September 28, 2008
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment